简体中文 | 繁體中文 | English

Press Releases

2021-09-17 14:58 SolarWinds Strengthens International Footprint by Opening South Korean Entity
2021-09-17 14:09 Altana, Beiten Burkhardt and Nctm Form ADVANT, a New European Law Firm Association
2021-09-17 14:04 Europcar Brazil Places Order for 50 Skyworks Aeronautics eGyro™ Electric Aircraft
2021-09-17 14:00 Diligent Announces 2021 Modern Governance 100 Honorees
2021-09-17 11:47 Alvaria Announces New CX and WEM Technology Solutions Scaled for the Enterprise
2021-09-17 11:07 Tech Mahindra Partners with the World’s Best University for Sport, Loughborough University
2021-09-17 10:09 MSCI Launches Implied Temperature Rise to Help Investors Align Their Portfolios With Global Climate Goals
2021-09-17 09:36 Rimini Street Introduces Board Members Jay Snyder and Katrinka McCallum
2021-09-17 09:14 GARP Survey Finds Significant Increases in Use of Scenario Analysis to Manage Climate Change Risk
2021-09-17 09:08 Boehringer Ingelheim Enters Clinical Collaboration with Amgen to Study BI 1701963, a SOS1::pan-KRAS Inhibitor, in Combination with LUMAKRAS™ (sotorasib), a KRASG12C Inhibitor
2021-09-16 19:22 The LYCRA Company Introduces LYCRA® ADAPTIV Fiber -- Allowing Garments to Adjust to Each Person’s Needs, Movements, Lifestyle and Body Fluctuations for a Better Wearing Experience
2021-09-16 19:16 Philip Morris International Announces Unconditional Offer for Vectura Group PLC
2021-09-16 16:39 Xendit Secures $150 Million Series C to Build Out Digital Payment Infrastructure Across Southeast Asia
2021-09-16 16:30 Trividia Health Announces Jonathan Chapman as President and Chief Executive Officer
2021-09-16 15:23 Elliptic Labs Launches AI Virtual Smart SensorTM on Xiaomi Mi 11T Smartphone
2021-09-16 15:09 Mary Kay Inc. Releases 2020-21 Sustainability & Social Impact Strategic Summary Report Highlighting Global Sustainability and Social Impact Goals Through 2030
2021-09-16 13:54 Gradiant Achieves Strong Growth in Cleantech Water Treatment during the Pandemic
2021-09-16 13:51 Vifor Pharma and Travere Therapeutics announce licensing agreement for the commercialization of sparsentan in Europe, Australia and New Zealand
2021-09-16 12:04 Virpax® Pharmaceuticals Announces Pricing of $40 Million Public Offering of Common Stock
2021-09-16 12:00 Andersen Global Enters Market in Southeast Asia

Business Wire Weibo

Industries

Latest Releases